APO Research
Talk to an analyst

APO RESEARCH · REPORT

Duloxetine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Duloxetine Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchDuloxetine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Duloxetine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Duloxetine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Duloxetine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Duloxetine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Duloxetine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Duloxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Duloxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Duloxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Duloxetine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Duloxetine include Teva, Sun Pharma, Eli Lilly, Zydus Pharmaceuticals, Jiangsu Nhwa Pharmaceutical, Torrent Pharmaceuticals, MACLEODS, Lupin and CSPC Ouyi Pharm, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Duloxetine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Duloxetine, also provides the revenue of main regions and countries. Of the upcoming market potential for Duloxetine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Duloxetine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Duloxetine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Duloxetine revenue, projected growth trends, production technology, application and end-user industry.

Duloxetine Segment by Company

Teva

Sun Pharma

Eli Lilly

Zydus Pharmaceuticals

Jiangsu Nhwa Pharmaceutical

Torrent Pharmaceuticals

MACLEODS

Lupin

CSPC Ouyi Pharm

Breckenridge

Aurobindo Pharma

Apotex

Ajanta Pharma

Duloxetine Segment by Type

60mg Capsules

40mg Capsules

30mg Capsules

20mg Capsules

Duloxetine Segment by Application

Hospital

Drug store

Duloxetine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Duloxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Duloxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Duloxetine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Duloxetine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Duloxetine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Duloxetine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Duloxetine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 60mg Capsules Major Player Table 3. 40mg Capsules Major Player Table 4. 30mg Capsules Major Player Table 5. 20mg Capsules Major Player Table 6. Global Duloxetine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Drug store Major Player Table 9. Duloxetine Industry Trends Table 10. Duloxetine Industry Drivers Table 11. Duloxetine Industry Opportunities and Challenges Table 12. Duloxetine Industry Restraints Table 13. Global Duloxetine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Duloxetine Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Duloxetine Market Share by Region (2021-2026) Table 16. Global Duloxetine Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Duloxetine Market Share by Region (2027-2032) Table 18. Global Duloxetine Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Duloxetine Revenue Market Share by Players (2021-2026) Table 20. Global Duloxetine Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Duloxetine Key Players Headquarters & Area Served Table 22. Global Duloxetine Players, Product Type & Application Table 23. Global Duloxetine Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Duloxetine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Duloxetine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Duloxetine Revenue Market Share by Type (2021-2026) Table 30. Global Duloxetine Revenue Market Share by Type (2027-2032) Table 31. Global Duloxetine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Duloxetine Revenue Market Share by Application (2021-2026) Table 35. Global Duloxetine Revenue Market Share by Application (2027-2032) Table 36. Teva Company Information Table 37. Teva Business Overview Table 38. Teva Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Teva Duloxetine Product Portfolio Table 40. Teva Recent Development Table 41. Sun Pharma Company Information Table 42. Sun Pharma Business Overview Table 43. Sun Pharma Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sun Pharma Duloxetine Product Portfolio Table 45. Sun Pharma Recent Development Table 46. Eli Lilly Company Information Table 47. Eli Lilly Business Overview Table 48. Eli Lilly Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eli Lilly Duloxetine Product Portfolio Table 50. Eli Lilly Recent Development Table 51. Zydus Pharmaceuticals Company Information Table 52. Zydus Pharmaceuticals Business Overview Table 53. Zydus Pharmaceuticals Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Zydus Pharmaceuticals Duloxetine Product Portfolio Table 55. Zydus Pharmaceuticals Recent Development Table 56. Jiangsu Nhwa Pharmaceutical Company Information Table 57. Jiangsu Nhwa Pharmaceutical Business Overview Table 58. Jiangsu Nhwa Pharmaceutical Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Jiangsu Nhwa Pharmaceutical Duloxetine Product Portfolio Table 60. Jiangsu Nhwa Pharmaceutical Recent Development Table 61. Torrent Pharmaceuticals Company Information Table 62. Torrent Pharmaceuticals Business Overview Table 63. Torrent Pharmaceuticals Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Torrent Pharmaceuticals Duloxetine Product Portfolio Table 65. Torrent Pharmaceuticals Recent Development Table 66. MACLEODS Company Information Table 67. MACLEODS Business Overview Table 68. MACLEODS Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. MACLEODS Duloxetine Product Portfolio Table 70. MACLEODS Recent Development Table 71. Lupin Company Information Table 72. Lupin Business Overview Table 73. Lupin Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Lupin Duloxetine Product Portfolio Table 75. Lupin Recent Development Table 76. CSPC Ouyi Pharm Company Information Table 77. CSPC Ouyi Pharm Business Overview Table 78. CSPC Ouyi Pharm Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. CSPC Ouyi Pharm Duloxetine Product Portfolio Table 80. CSPC Ouyi Pharm Recent Development Table 81. Breckenridge Company Information Table 82. Breckenridge Business Overview Table 83. Breckenridge Duloxetine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Breckenridge Duloxetine Product Portfolio Table 85. Breckenridge Recent Development Table 86. Aurobindo Pharma Company Information Table 87. Aurobindo Pharma Business Overview Table 88. Aurobindo Pharma Duloxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Aurobindo Pharma Duloxetine Product Portfolio Table 90. Aurobindo Pharma Recent Development Table 91. Apotex Company Information Table 92. Apotex Business Overview Table 93. Apotex Duloxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Apotex Duloxetine Product Portfolio Table 95. Apotex Recent Development Table 96. Ajanta Pharma Company Information Table 97. Ajanta Pharma Business Overview Table 98. Ajanta Pharma Duloxetine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Ajanta Pharma Duloxetine Product Portfolio Table 100. Ajanta Pharma Recent Development Table 101. North America Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Duloxetine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Duloxetine Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Duloxetine Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Duloxetine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Duloxetine Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Duloxetine Revenue by Country (US$ Million) & (2027-2032) Table 115. China Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 116. China Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 117. China Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 118. China Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Duloxetine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Duloxetine Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Duloxetine Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Duloxetine Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Duloxetine Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Duloxetine Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Duloxetine Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Duloxetine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Duloxetine Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Duloxetine Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Duloxetine Image Figure 2. Global Duloxetine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Duloxetine Market Size Share 2021 VS 2025 VS 2032 Figure 4. 60mg Capsules Image Figure 5. 40mg Capsules Image Figure 6. 30mg Capsules Image Figure 7. 20mg Capsules Image Figure 8. Global Duloxetine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Duloxetine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Drug store Image Figure 12. Global Duloxetine Market Size (US$ Million) & (2021-2032) Figure 13. Global Duloxetine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Duloxetine Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Duloxetine Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Duloxetine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Duloxetine Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Duloxetine Revenue Market Share by Type (2021-2032) Figure 20. Global Duloxetine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Duloxetine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Duloxetine Revenue Market Share by Application (2021-2032) Figure 23. North America Duloxetine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Duloxetine Revenue Share by Type (2021-2032) Figure 25. North America Duloxetine Revenue Share by Application (2021-2032) Figure 26. North America Duloxetine Revenue Share by Country (2021-2032) Figure 27. United States Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Duloxetine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Duloxetine Revenue Share by Type (2021-2032) Figure 32. Europe Duloxetine Revenue Share by Application (2021-2032) Figure 33. Europe Duloxetine Revenue Share by Country (2021-2032) Figure 34. Germany Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Duloxetine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Duloxetine Revenue Share by Type (2021-2032) Figure 44. China Duloxetine Revenue Share by Application (2021-2032) Figure 45. Asia Duloxetine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Duloxetine Revenue Share by Type (2021-2032) Figure 47. Asia Duloxetine Revenue Share by Application (2021-2032) Figure 48. Asia Duloxetine Revenue Share by Region (2021-2032) Figure 49. Japan Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Duloxetine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Duloxetine Revenue Share by Type (2021-2032) Figure 57. SAMEA Duloxetine Revenue Share by Application (2021-2032) Figure 58. SAMEA Duloxetine Revenue Share by Country (2021-2032) Figure 59. Brazil Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Duloxetine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg Capsules
  • 40mg Capsules
  • 30mg Capsules
  • 20mg Capsules
Applications
  • Hospital
  • Drug store
Companies covered
  • Teva
  • Sun Pharma
  • Eli Lilly
  • Zydus Pharmaceuticals
  • Jiangsu Nhwa Pharmaceutical
  • Torrent Pharmaceuticals
  • MACLEODS
  • Lupin
  • CSPC Ouyi Pharm
  • Breckenridge
  • Aurobindo Pharma
  • Apotex
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Duloxetine Market by Type
  3. 1.2.1 Global Duloxetine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 60mg Capsules
  5. 1.2.3 40mg Capsules
  6. 1.2.4 30mg Capsules
  7. 1.2.5 20mg Capsules
  8. 1.3 Duloxetine Market by Application
  9. 1.3.1 Global Duloxetine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Drug store
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Duloxetine Market Dynamics
  1. 2.1 Duloxetine Industry Trends
  2. 2.2 Duloxetine Industry Drivers
  3. 2.3 Duloxetine Industry Opportunities and Challenges
  4. 2.4 Duloxetine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Duloxetine Market Perspective (2021-2032)
  2. 3.2 Global Duloxetine Growth Trends by Region
  3. 3.2.1 Global Duloxetine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Duloxetine Market Size by Region (2021-2026)
  5. 3.2.3 Global Duloxetine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Duloxetine Revenue by Players
  2. 4.1.1 Global Duloxetine Revenue by Players (2021-2026)
  3. 4.1.2 Global Duloxetine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Duloxetine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Duloxetine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Duloxetine Key Players Headquarters & Area Served
  7. 4.4 Global Duloxetine Players, Product Type & Application
  8. 4.5 Global Duloxetine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Duloxetine Market CR5 and HHI
  11. 4.6.3 2025 Duloxetine Tier 1, Tier 2, and Tier 3
5 Duloxetine Market Size by Type
  1. 5.1 Global Duloxetine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Duloxetine Revenue by Type (2021-2032)
  3. 5.3 Global Duloxetine Revenue Market Share by Type (2021-2032)
6 Duloxetine Market Size by Application
  1. 6.1 Global Duloxetine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Duloxetine Revenue by Application (2021-2032)
  3. 6.3 Global Duloxetine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Duloxetine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Duloxetine Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Sun Pharma
  8. 7.2.1 Sun Pharma Company Information
  9. 7.2.2 Sun Pharma Business Overview
  10. 7.2.3 Sun Pharma Duloxetine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sun Pharma Duloxetine Product Portfolio
  12. 7.2.5 Sun Pharma Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Duloxetine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Duloxetine Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 Zydus Pharmaceuticals
  20. 7.4.1 Zydus Pharmaceuticals Company Information
  21. 7.4.2 Zydus Pharmaceuticals Business Overview
  22. 7.4.3 Zydus Pharmaceuticals Duloxetine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Zydus Pharmaceuticals Duloxetine Product Portfolio
  24. 7.4.5 Zydus Pharmaceuticals Recent Developments
  25. 7.5 Jiangsu Nhwa Pharmaceutical
  26. 7.5.1 Jiangsu Nhwa Pharmaceutical Company Information
  27. 7.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
  28. 7.5.3 Jiangsu Nhwa Pharmaceutical Duloxetine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Jiangsu Nhwa Pharmaceutical Duloxetine Product Portfolio
  30. 7.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
  31. 7.6 Torrent Pharmaceuticals
  32. 7.6.1 Torrent Pharmaceuticals Company Information
  33. 7.6.2 Torrent Pharmaceuticals Business Overview
  34. 7.6.3 Torrent Pharmaceuticals Duloxetine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Torrent Pharmaceuticals Duloxetine Product Portfolio
  36. 7.6.5 Torrent Pharmaceuticals Recent Developments
  37. 7.7 MACLEODS
  38. 7.7.1 MACLEODS Company Information
  39. 7.7.2 MACLEODS Business Overview
  40. 7.7.3 MACLEODS Duloxetine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 MACLEODS Duloxetine Product Portfolio
  42. 7.7.5 MACLEODS Recent Developments
  43. 7.8 Lupin
  44. 7.8.1 Lupin Company Information
  45. 7.8.2 Lupin Business Overview
  46. 7.8.3 Lupin Duloxetine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Lupin Duloxetine Product Portfolio
  48. 7.8.5 Lupin Recent Developments
  49. 7.9 CSPC Ouyi Pharm
  50. 7.9.1 CSPC Ouyi Pharm Company Information
  51. 7.9.2 CSPC Ouyi Pharm Business Overview
  52. 7.9.3 CSPC Ouyi Pharm Duloxetine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CSPC Ouyi Pharm Duloxetine Product Portfolio
  54. 7.9.5 CSPC Ouyi Pharm Recent Developments
  55. 7.10 Breckenridge
  56. 7.10.1 Breckenridge Company Information
  57. 7.10.2 Breckenridge Business Overview
  58. 7.10.3 Breckenridge Duloxetine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Breckenridge Duloxetine Product Portfolio
  60. 7.10.5 Breckenridge Recent Developments
  61. 7.11 Aurobindo Pharma
  62. 7.11.1 Aurobindo Pharma Company Information
  63. 7.11.2 Aurobindo Pharma Business Overview
  64. 7.11.3 Aurobindo Pharma Duloxetine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aurobindo Pharma Duloxetine Product Portfolio
  66. 7.11.5 Aurobindo Pharma Recent Developments
  67. 7.12 Apotex
  68. 7.12.1 Apotex Company Information
  69. 7.12.2 Apotex Business Overview
  70. 7.12.3 Apotex Duloxetine Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Apotex Duloxetine Product Portfolio
  72. 7.12.5 Apotex Recent Developments
  73. 7.13 Ajanta Pharma
  74. 7.13.1 Ajanta Pharma Company Information
  75. 7.13.2 Ajanta Pharma Business Overview
  76. 7.13.3 Ajanta Pharma Duloxetine Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Ajanta Pharma Duloxetine Product Portfolio
  78. 7.13.5 Ajanta Pharma Recent Developments
8 North America
  1. 8.1 North America Duloxetine Revenue (2021-2032)
  2. 8.2 North America Duloxetine Revenue by Type (2021-2032)
  3. 8.2.1 North America Duloxetine Revenue by Type (2021-2026)
  4. 8.2.2 North America Duloxetine Revenue by Type (2027-2032)
  5. 8.3 North America Duloxetine Revenue Share by Type (2021-2032)
  6. 8.4 North America Duloxetine Revenue by Application (2021-2032)
  7. 8.4.1 North America Duloxetine Revenue by Application (2021-2026)
  8. 8.4.2 North America Duloxetine Revenue by Application (2027-2032)
  9. 8.5 North America Duloxetine Revenue Share by Application (2021-2032)
  10. 8.6 North America Duloxetine Revenue by Country
  11. 8.6.1 North America Duloxetine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Duloxetine Revenue by Country (2021-2026)
  13. 8.6.3 North America Duloxetine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Duloxetine Revenue (2021-2032)
  2. 9.2 Europe Duloxetine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Duloxetine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Duloxetine Revenue by Type (2027-2032)
  5. 9.3 Europe Duloxetine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Duloxetine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Duloxetine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Duloxetine Revenue by Application (2027-2032)
  9. 9.5 Europe Duloxetine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Duloxetine Revenue by Country
  11. 9.6.1 Europe Duloxetine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Duloxetine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Duloxetine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Duloxetine Revenue (2021-2032)
  2. 10.2 China Duloxetine Revenue by Type (2021-2032)
  3. 10.2.1 China Duloxetine Revenue by Type (2021-2026)
  4. 10.2.2 China Duloxetine Revenue by Type (2027-2032)
  5. 10.3 China Duloxetine Revenue Share by Type (2021-2032)
  6. 10.4 China Duloxetine Revenue by Application (2021-2032)
  7. 10.4.1 China Duloxetine Revenue by Application (2021-2026)
  8. 10.4.2 China Duloxetine Revenue by Application (2027-2032)
  9. 10.5 China Duloxetine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Duloxetine Revenue (2021-2032)
  2. 11.2 Asia Duloxetine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Duloxetine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Duloxetine Revenue by Type (2027-2032)
  5. 11.3 Asia Duloxetine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Duloxetine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Duloxetine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Duloxetine Revenue by Application (2027-2032)
  9. 11.5 Asia Duloxetine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Duloxetine Revenue by Country
  11. 11.6.1 Asia Duloxetine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Duloxetine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Duloxetine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Duloxetine Revenue (2021-2032)
  2. 12.2 SAMEA Duloxetine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Duloxetine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Duloxetine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Duloxetine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Duloxetine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Duloxetine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Duloxetine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Duloxetine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Duloxetine Revenue by Country
  11. 12.6.1 SAMEA Duloxetine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Duloxetine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Duloxetine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst